CD274 and Burkitt lymphoma: Given the strong increase of PD-L1 expression in EBNA2-transfected BL and DLBCLs and since miR-34a targets PD-L1, we set out to investigate if miR-34a expression is affected in EBNA2-expressing B lymphoma cells.